BioStock: Saniona’s CEO shares 2024 business development roadmap

Saniona is focusing on partnering and investing the proceeds from such partnerships to build shareholder value. The goal is long-term success and being less reliant on conventional financing routes. In an interview with BioStock, Saniona’s CEO Thomas Feldthus talks about this in more detail. We also learn more about the new focus on epilepsy treatment and the potential share issue of 140 million SEK in January.

Read the full interview with Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2023/12/sanionas-ceo-shares-2024-business-development-roadmap/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/